Open access · OA
via OpenAlex
Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells
Brian Bierie, Sarah E. Pierce, Cornelia Kroeger, Daniel G. Stover, Diwakar R. Pattabiraman, Prathapan Thiru, Joana Liu Donaher, Ferenc Reinhardt, Christine L. Chaffer, Zuzana Keckesova, Robert A. Weinberg
Proceedings of the National Academy of Sciences · 2017 · ▲ 374 citations
Abstract
cancer stem cell (CSC)-enriched mesenchymal cells reside in an intermediate epithelial/mesenchymal phenotypic state. Among patients with TNBC who received chemotherapy, elevated ITGB4 expression was associated with a worse 5-year probability of relapse-free survival. Mechanistically, we find that the ZEB1 (zinc finger E-box binding homeobox 1) transcription factor activity in highly mesenchymal SUM159 TNBC cells can repress expression of the epithelial transcription factor TAp63α (tumor protein 63 isoform 1), a protein that promotes ITGB4 expression. In addition, we demonstrate that ZEB1 and ITGB4 are important in modulating the histopathological phenotypes of tumors derived from mesenchymal TNBC cells. Hence, mesenchymal carcinoma cell populations are internally heterogeneous, and ITGB4 is a mechanistically driven prognostic biomarker that can be used to identify the more aggressive subtypes of mesenchymal carcinoma cells in TNBC. The ability to rapidly isolate and mechanistically interrogate the CSC-enriched, partially mesenchymal carcinoma cells should further enable identification of novel therapeutic opportunities to improve the prognosis for high-risk patients with TNBC.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1073/pnas.1618298114
- Canonical
- link ↗
- Fetched
- 2026-08-31 MST
Cite this
APA
Bierie, B., Pierce, S.E., Kroeger, C., Stover, D.G., Pattabiraman, D.R., Thiru, P., Donaher, J.L., Reinhardt, F., Chaffer, C.L., Keckesova, Z., & Weinberg, R.A. (2017). Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. <em>Proceedings of the National Academy of Sciences</em>. https://doi.org/10.1073/pnas.1618298114
Vancouver
Bierie B, Pierce SE, Kroeger C, Stover DG, Pattabiraman DR, Thiru P, et al. Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. Proceedings of the National Academy of Sciences. 2017. doi:10.1073/pnas.1618298114.
BibTeX
@article{brian2017Integr,
title = {Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells},
author = {Brian Bierie and Sarah E. Pierce and Cornelia Kroeger and Daniel G. Stover and Diwakar R. Pattabiraman and Prathapan Thiru and Joana Liu Donaher and Ferenc Reinhardt and Christine L. Chaffer and Zuzana Keckesova and Robert A. Weinberg},
journal = {Proceedings of the National Academy of Sciences},
year = {2017},
doi = {10.1073/pnas.1618298114},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Elsevier eBooks 2009
Citation only
Mesenchymal Stem Cells
Thorax 2024
Citation only
S150 Effects of putative senotherapies, fisetin and navitoclax, on senescent small airway fibroblasts in COPD
Journal of Molecular Medicine 2023
Citation only
Potential role of mesenchymal stem cells in T cell aging
In Vivo 2023
Open access · CC-BY
The Role of Box A ofHMGB1in Enhancing Stem Cell Properties of Human Mesenchymal Cells: A Novel Approach for the Pursuit of Anti-aging Therapy
Cells 2021
Open access · CC-BY
Age-Related Changes in Bone-Marrow Mesenchymal Stem Cells
Cytokine & Growth Factor Reviews 2009
Open access · OA